Related Experiment Video
Updated: Jun 21, 2026

Ultrasonic Assessment of Myocardial Microstructure
Published on: January 14, 2014
Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption
1Department of Cardiology, Pneumology, and Angiology, School of Internal Medicine, Heinrich-Heine-University, Düsseldorf, Germany. heidland@med.uni-duesseldorf.de
Insights
Hemodynamic forces, increased left ventricular muscle mass, and higher heart rates are linked to plaque disruption in coronary atherosclerosis. Beta-blocker use was associated with a lower risk of plaque disruption.
Area of Science:
- Cardiology
- Cardiovascular Pathophysiology
- Atherosclerosis Research
Background:
- Plaque disruption is a key factor in acute coronary syndromes and atherosclerosis progression.
- Limited information exists regarding factors contributing to plaque disruption.
- This study investigates the role of hemodynamic forces in plaque disruption pathogenesis.
Purpose of the Study:
- To analyze the contribution of hemodynamic forces to the pathogenesis of plaque disruption.
- To identify factors associated with plaque disruption in patients with coronary stenosis.
Main Methods:
- Retrospective analysis of 106 patients undergoing two coronary angiograms within six months.
- Comparison of 53 patients with plaque disruption versus 53 controls with stable stenoses.
- Analysis of central hemodynamics, echocardiographic measurements, and medication use.
Main Results:
- Logistic regression identified increased left ventricular muscle mass (>270 g) and mean heart rate (>80 bpm) as positively associated with plaque disruption.
- Use of beta-blockers showed a negative association with plaque disruption.
- Plaque disruption was diagnosed via coronary angiography in stenosed arteries.
Conclusions:
- Hemodynamic forces appear to play a significant role in the pathogenesis of plaque disruption.
- Findings may aid in identifying high-risk patients for plaque disruption.
- Pharmacological interventions targeting heart rate reduction (e.g., beta-blockers) and left ventricular hypertrophy may be beneficial.
Background:
Plaque disruption is the central pathophysiological mechanism underlying acute coronary syndromes and the progression of coronary atherosclerosis. There exists only scant information about the factors that are associated with its development. The aim of the current study was to analyze the contribution of hemodynamic forces in the pathogenesis of plaque disruption. Plaque disruption was diagnosed by coronary angiography of stenosed but not completely occluded coronary arteries.
Methods And Results:
This study retrospectively analyzed 106 patients who underwent 2 coronary angiography procedures within 6 months. We investigated 53 patients with initially smooth stenoses who developed plaque disruption by the time of the second coronary angiogram and compared these patients with 53 age- and sex-matched individuals with smooth stenoses without angiographic signs of plaque disruption. The 2 groups were compared by analyzing central hemodynamics, echocardiographic measurements, and cardiovascular medication use. Logistic regression analysis identified positive associations between plaque disruption, left ventricular muscle mass >270 g, and a mean heart rate >80 bpm and a negative association with the use of beta-blockers.
Conclusions:
The associations documented by our investigation indicate that hemodynamic forces may play a crucial role in the pathogenesis of plaque disruption. These findings may help to identify patients who are at an increased risk of plaque disruption and who might gain benefit from pharmacological interventions aimed at reducing heart rate, for example, by the use of beta-blockers, or a reduction of left ventricular hypertrophy.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Stenosis I: Introduction
Myocarditis I: Introduction
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Heart Failure II: Pathophysiology

